SEBELA PHARMACEUTICALS INC. Trademark

Trademark Overview

On Tuesday, September 27, 2016, a trademark application was filed for SEBELA PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the SEBELA PHARMACEUTICALS INC. trademark a serial number of 87184990. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2019. This trademark is owned by Sebela International Limited. The SEBELA PHARMACEUTICALS INC. trademark is filed in the Pharmaceutical Products category with the following description:

Contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; all of the aforesaid goods not for use as a product name of a pharmaceutical product
sebela pharmaceuticals inc.

General Information

Serial Number87184990
Word MarkSEBELA PHARMACEUTICALS INC.
Filing DateTuesday, September 27, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS INC."
Goods and ServicesContraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; all of the aforesaid goods not for use as a product name of a pharmaceutical product
Translation of Words in MarkThe wording "SEBELA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 30, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSEBELA INTERNATIONAL BERMUDA LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressHAMILTON HM 09
BM
Party NameSebela International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHamilton HM09
BM
Party NameSebela International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHamilton HM09
BM

Trademark Events

Event DateEvent Description
Tuesday, May 28, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 27, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 25, 2018EXTENSION 3 GRANTED
Thursday, October 25, 2018EXTENSION 3 FILED
Thursday, October 25, 2018TEAS EXTENSION RECEIVED
Wednesday, July 4, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2018CORRECTED NOA E-MAILED
Thursday, April 5, 2018EXTENSION 2 GRANTED
Thursday, March 29, 2018EXTENSION 2 FILED
Thursday, April 5, 2018DIVISIONAL PROCESSING COMPLETE
Thursday, March 29, 2018DIVISIONAL REQUEST RECEIVED
Thursday, March 29, 2018TEAS REQUEST TO DIVIDE RECEIVED
Thursday, March 29, 2018TEAS EXTENSION RECEIVED
Thursday, October 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2017CORRECTED NOA E-MAILED
Wednesday, October 18, 2017EXTENSION 1 GRANTED
Tuesday, October 10, 2017EXTENSION 1 FILED
Wednesday, October 18, 2017DIVISIONAL PROCESSING COMPLETE
Tuesday, October 10, 2017DIVISIONAL REQUEST RECEIVED
Wednesday, October 18, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 10, 2017TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 10, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 10, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, April 3, 2017ASSIGNED TO PETITION STAFF
Tuesday, March 28, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, January 10, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 10, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, January 10, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 4, 2017ASSIGNED TO EXAMINER
Friday, September 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 30, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals sebela pharmaceutical preparations product treatment endometriosis vaginitis osteoporosis infertility dysfunction female